144 related articles for article (PubMed ID: 33109386)
1. Effect of Food on the Pharmacokinetic and Pharmacodynamic Profiles of Hetrombopag in Healthy Volunteers.
Wang Z; Chen X; Li A; Chen L; Wang Y; Zheng L
Clin Ther; 2020 Dec; 42(12):2280-2288. PubMed ID: 33109386
[TBL] [Abstract][Full Text] [Related]
2. Effect of postdose fasting duration on hetrombopag olamine pharmacokinetics and pharmacodynamics in healthy volunteers.
Yang G; Huang R; Yang S; Zhang X; Yang X; Chen H; Huang Z; Guo C; Pei Q; Tai Y; Shen Y; Huang J; Zou C
Br J Clin Pharmacol; 2020 Aug; 86(8):1528-1536. PubMed ID: 32069516
[TBL] [Abstract][Full Text] [Related]
3. Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Individuals.
Zheng L; Liang MZ; Zeng XL; Li CZ; Zhang YF; Chen XY; Zhu X; Xiang AB
Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):414-422. PubMed ID: 28544774
[TBL] [Abstract][Full Text] [Related]
4. Impact of target-mediated drug disposition on hetrombopag pharmacokinetics and pharmacodynamics in Chinese healthy subjects and patients with chronic idiopathic thrombocytopenic purpura.
Wang Z; Zeng Z; Ye L; Zhu X; Pei Y; Wang Y; Zheng L
Br J Clin Pharmacol; 2022 May; 88(5):2084-2095. PubMed ID: 34705278
[TBL] [Abstract][Full Text] [Related]
5. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
[TBL] [Abstract][Full Text] [Related]
6. First-in-patient study of hetrombopag in patients with chronic idiopathic thrombocytopenic purpura.
Wang Z; Chen L; Zhang F; Lu H; Chen X; Wen A; Luo J; Hu Y; Wang Y; Niu T; Zheng L
J Thromb Haemost; 2020 Nov; 18(11):3053-3060. PubMed ID: 32865293
[TBL] [Abstract][Full Text] [Related]
7. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
[TBL] [Abstract][Full Text] [Related]
8. A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food.
Zomorodi K; Kankam M; Lu Y
Clin Ther; 2019 Feb; 41(2):196-204. PubMed ID: 30598342
[TBL] [Abstract][Full Text] [Related]
9. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
[TBL] [Abstract][Full Text] [Related]
10. Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers.
Rioux N; Kim A; Nix D; Bowser T; Warmuth M; Smith PG; Schindler J
Cancer Chemother Pharmacol; 2019 Jan; 83(1):91-96. PubMed ID: 30368584
[TBL] [Abstract][Full Text] [Related]
11. Effects of Food and Calcium Carbonate on the Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist.
Katsube T; Wajima T; Fukuhara T; Kano T
Clin Ther; 2019 Sep; 41(9):1747-1754.e2. PubMed ID: 31303281
[TBL] [Abstract][Full Text] [Related]
12. Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects.
Qian H; Fan S; Li K; Sai Y; Su W; Chen Q; Liu Y; Li T; Wang W; Jia J; Yu C; Liu Y
Clin Ther; 2019 Aug; 41(8):1537-1544. PubMed ID: 31272709
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
Mei H; Liu X; Li Y; Zhou H; Feng Y; Gao G; Cheng P; Huang R; Yang L; Hu J; Hou M; Yao Y; Liu L; Wang Y; Wu D; Zhang L; Zheng C; Shen X; Hu Q; Liu J; Jin J; Luo J; Zeng Y; Gao S; Zhang X; Zhou X; Shi Q; Xia R; Xie X; Jiang Z; Gao L; Bai Y; Li Y; Xiong J; Li R; Zou J; Niu T; Yang R; Hu Y
J Hematol Oncol; 2021 Feb; 14(1):37. PubMed ID: 33632264
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
Sikes C; Stark JG; McMahen R; Engelking D
Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
[TBL] [Abstract][Full Text] [Related]
15. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
[TBL] [Abstract][Full Text] [Related]
16. Hetrombopag: First Approval.
Syed YY
Drugs; 2021 Sep; 81(13):1581-1585. PubMed ID: 34357499
[TBL] [Abstract][Full Text] [Related]
17. Effects of Differential Food Patterns on the Pharmacokinetics of Enteric-Coated Mesalazine Tablets in the Same Cohort of Healthy Chinese Volunteers.
Zhang SH; Li Y; Wei SS; Guo L; Huang XM; Chen Y; Wu XX; Cai HL; Zhang BK
Clin Pharmacol Drug Dev; 2020 Jan; 9(1):41-49. PubMed ID: 31056855
[TBL] [Abstract][Full Text] [Related]
18. Effect of meal timing on pharmacokinetics and pharmacodynamics of tegoprazan in healthy male volunteers.
Yoon DY; Sunwoo J; Shin N; Kim AR; Kim B; Song GS; Jang IJ; Lee S
Clin Transl Sci; 2021 May; 14(3):934-941. PubMed ID: 33382926
[TBL] [Abstract][Full Text] [Related]
19. Food Effect Study to Assess the Impact on Edaravone Pharmacokinetic Profiles in Healthy Participants.
Shimizu H; Nishimura Y; Shiide Y; Akimoto M; Matsuda H; Kato Y; Hirai M
Clin Ther; 2022 Dec; 44(12):1552-1565. PubMed ID: 36376130
[TBL] [Abstract][Full Text] [Related]
20. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
Godfrey AR; Digiacinto J; Davis MW
Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
